These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23333709)

  • 1. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size.
    Sinha B; Müller RH; Möschwitzer JP
    Int J Pharm; 2013 Aug; 453(1):126-41. PubMed ID: 23333709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug nanocrystals in the commercial pharmaceutical development process.
    Möschwitzer JP
    Int J Pharm; 2013 Aug; 453(1):142-56. PubMed ID: 23000841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosizing techniques for improving bioavailability of drugs.
    Al-Kassas R; Bansal M; Shaw J
    J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches.
    Salazar J; Ghanem A; Müller RH; Möschwitzer JP
    Eur J Pharm Biopharm; 2012 May; 81(1):82-90. PubMed ID: 22233547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of precipitation methods for the production of water-insoluble drug nanocrystals: production techniques and stability of nanocrystals.
    Xia D; Gan Y; Cui F
    Curr Pharm Des; 2014; 20(3):408-35. PubMed ID: 23651396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals - A comprehensive review.
    Padrela L; Rodrigues MA; Duarte A; Dias AMA; Braga MEM; de Sousa HC
    Adv Drug Deliv Rev; 2018 Jun; 131():22-78. PubMed ID: 30026127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic investigation of the cavi-precipitation process for the production of ibuprofen nanocrystals.
    Sinha B; Müller RH; Möschwitzer JP
    Int J Pharm; 2013 Dec; 458(2):315-23. PubMed ID: 24148667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
    Shegokar R; Müller RH
    Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of pure drug nanocrystals and nano co-crystals by confinement methods.
    Fontana F; Figueiredo P; Zhang P; Hirvonen JT; Liu D; Santos HA
    Adv Drug Deliv Rev; 2018 Jun; 131():3-21. PubMed ID: 29738786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
    Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
    Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel high-pressure precipitation tandem homogenization technology for drug nanocrystals production - a case study with ursodeoxycholic acid.
    Li Y; Wang Y; Yue PF; Hu PY; Wu ZF; Yang M; Yuan HL
    Pharm Dev Technol; 2014 Sep; 19(6):662-70. PubMed ID: 23869484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches.
    Zhang H; Meng Y; Wang X; Dai W; Wang X; Zhang Q
    Drug Deliv; 2014 Dec; 21(8):588-94. PubMed ID: 24320001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
    Sheth P; Sandhu H; Singhal D; Malick W; Shah N; Kislalioglu MS
    Curr Drug Deliv; 2012 May; 9(3):269-84. PubMed ID: 22283656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance comparison of two novel combinative particle-size-reduction technologies.
    Salazar J; Müller RH; Möschwitzer JP
    J Pharm Sci; 2013 May; 102(5):1636-49. PubMed ID: 23436640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical nanocrystals: production by wet milling and applications.
    Malamatari M; Taylor KMG; Malamataris S; Douroumis D; Kachrimanis K
    Drug Discov Today; 2018 Mar; 23(3):534-547. PubMed ID: 29326082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
    Thakkar S; Shah V; Misra M; Kalia K
    Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery.
    Pawar VK; Singh Y; Meher JG; Gupta S; Chourasia MK
    J Control Release; 2014 Jun; 183():51-66. PubMed ID: 24667572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precipitation-lyophilization-homogenization (PLH) for preparation of clarithromycin nanocrystals: influencing factors on physicochemical properties and stability.
    Morakul B; Suksiriworapong J; Leanpolchareanchai J; Junyaprasert VB
    Int J Pharm; 2013 Nov; 457(1):187-96. PubMed ID: 24076396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery.
    Lai F; Schlich M; Pireddu R; Corrias F; Fadda AM; Sinico C
    Curr Pharm Des; 2015; 21(42):6089-103. PubMed ID: 26503149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug nanocrystals - Versatile option for formulation of poorly soluble materials.
    Peltonen L; Hirvonen J
    Int J Pharm; 2018 Feb; 537(1-2):73-83. PubMed ID: 29262301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.